BIOCRYST PHARMACEUTICALS INC's ticker is BCRX and the CUSIP is 09058V103. A total of 172 filers reported holding BIOCRYST PHARMACEUTICALS INC in Q2 2020. The put-call ratio across all filers is 0.32 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2024 | $66 | -21.4% | 13,179 | -6.8% | 0.00% | – |
| Q4 2023 | $84 | +189.7% | 14,143 | +296.5% | 0.00% | – |
| Q1 2023 | $29 | -27.5% | 3,567 | 0.0% | 0.00% | – |
| Q4 2022 | $40 | -99.9% | 3,567 | 0.0% | 0.00% | – |
| Q3 2022 | $44,000 | +18.9% | 3,567 | 0.0% | 0.00% | – |
| Q2 2022 | $37,000 | -35.1% | 3,567 | 0.0% | 0.00% | – |
| Q1 2022 | $57,000 | +23.9% | 3,567 | +10.2% | 0.00% | – |
| Q3 2021 | $46,000 | +31.4% | 3,238 | -81.5% | 0.00% | – |
| Q1 2020 | $35,000 | – | 17,523 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RP Management, LLC | 3,846,154 | $40,692,000 | 16.07% |
| Fairmount Funds Management LLC | 3,343,107 | $35,370,000 | 8.10% |
| Kynam Capital Management, LP | 936,563 | $9,909,000 | 2.53% |
| Velan Capital Investment Management LP | 225,000 | $2,381,000 | 2.42% |
| ORACLE INVESTMENT MANAGEMENT INC | 603,994 | $6,390,000 | 1.94% |
| TANG CAPITAL MANAGEMENT LLC | 1,200,000 | $12,696,000 | 1.93% |
| MPM BioImpact LLC | 639,089 | $6,762,000 | 1.88% |
| Ghost Tree Capital, LLC | 325,000 | $3,439,000 | 1.79% |
| Sarissa Capital Management LP | 1,390,790 | $14,715,000 | 1.48% |
| Prosight Management, LP | 176,680 | $1,869,000 | 1.47% |